BIOSENSE WEBSTER INC PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
|
Back to Search Results |
|
Catalog Number D128211 |
Device Problems
Signal Artifact/Noise (1036); Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/11/2024 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a pentaray nav high-density mapping eco catheter and partial separation occurred.It was reported that during the operation, the signal interference (noise) was observed on ic, bs, or all ecg (bs + ic) channels.The physician removed the device from the patient, one spine of the catheter was found broken but no part fell off.A second device was used to complete the operation.Resistance was felt.
|
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
On 25-apr-2024, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a pentaray nav high-density mapping eco catheter and partial separation occurred.It was reported that during the operation, the signal interference (noise) was observed on ic, bs, or all ecg (bs + ic) channels.The physician removed the device from the patient, one spine of the catheter was found broken but no part fell off.A second device was used to complete the operation.Resistance was felt.Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.Visual inspection and electrical test of the returned device were performed following bwi procedures.Visual inspection was performed, a part of one of the splines was observed detached from the tip leaving internal components exposed.An electrical test could not be performed due to the damage to the device.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The tip and electrical issues reported by the customer were confirmed since the noise reported by the customer could be caused by the spline broken.The potential cause of the damage could be related to the manipulation of the device during the procedure, however, this cannot be conclusively determined.The instructions for use contain (ifu) the following warning and precaution: do not introduce the catheter into a guiding sheath with the catheter¿s distal spines folded backward toward the handle.Collapse the spines together using the insertion tube prior to insertion.Do not use excessive force to advance or withdraw the catheter through the guiding sheath when resistance is encountered.Prior to removing or repositioning the catheter, use direct imaging guidance such as fluoroscopy to confirm that the spine assembly is not entangled with another catheter or with an anatomical structure.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#(b)(4).
|
|
Search Alerts/Recalls
|
|
|